Who owns the REDAXIN trademark?

The REDAXIN trademark is owned by Redleaf Biologics, Inc..

What class is the REDAXIN trademark registered in?

The REDAXIN trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for REDAXIN?

The USPTO serial number for REDAXIN is 97488459.

What is the registration number for REDAXIN?

REDAXIN is registered under USPTO registration number 7672097.

Sealvo

Home Search: REDAXINREDAXIN #97488459

Back

Updated Oct 20, 2026·22 searches this week

View on USPTO TSDR Find similar marks

RED

USPTO Trademark Record

REGISTERED

REDAXIN

SN 97488459·Reg 7672097·Filed Jul 05, 2022

Owner Redleaf Biologics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

REDAXIN (Serial No. 97488459), Registration No. 7672097, is a registered US trademark filed on Jul 05, 2022 by Redleaf Biologics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: January 28, 2031

Mark Intelligence

REDAXIN (Reg. #7672097) is a registered US trademark that has been protecting its owner, Redleaf Biologics, Inc., since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 05, 2022

SERIAL

97488459

REG#

7672097

REGISTERED

Jan 28, 2025

Filing Information

StatusREGISTERED

Filing DateJul 05, 2022

Serial Number97488459

Registration No.7672097

Registration DateJan 28, 2025

Status DateJan 28, 2025

Published for OppositionMay 30, 2023

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 25, 2024

First use in commerce: Jul 25, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

24 events

REGISTERED-PRINCIPAL REGISTER

Jan 28, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 28, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 08, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 08, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jan 07, 2025

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 06, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Oct 21, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Oct 21, 2024

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 24, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jul 22, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jul 22, 2024

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Jul 22, 2024

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 27, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 25, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jan 25, 2024

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jan 25, 2024

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 25, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 30, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 30, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 10, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 25, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Apr 19, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 23, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 08, 2022

NEW APPLICATION ENTERED

Other Marks by Redleaf Biologics, Inc.

Additional USPTO filings from the same owner.

3DA

3-DAXIN

97214807

RedLeaf Biologics Inc.

REGISTERED

RED

REDAXIN

97488456

Redleaf Biologics, Inc.

PENDING

RED

REDAXIN

99392217

Redleaf Biologics, Inc.

PENDING

SOR

SORGOVIA

97488434

Redleaf Biologics, Inc.

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

RED

REDAXIN

99392217

Redleaf Biologics, Inc.

PENDING

Other Marks by Anthony F. Bonner, Jr.

Additional USPTO filings handled by the same attorney of record.

DIE

#DIESELTIPS

86946752

REGISTERED

THO

THOROUGHBRED DIESEL

98470058

REGISTERED

LEX

LEXINGTON CENTER

76456040

REGISTERED

LOG

LogoMark

76456041

REGISTERED

REDAXIN

Run a conflict check

Other Marks by Redleaf Biologics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Anthony F. Bonner, Jr.

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company